0001872295-21-000001.txt : 20210714
0001872295-21-000001.hdr.sgml : 20210714
20210714163503
ACCESSION NUMBER: 0001872295-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20210714
DATE AS OF CHANGE: 20210714
EFFECTIVENESS DATE: 20210714
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aditum Bio Fund 2, L.P.
CENTRAL INDEX KEY: 0001872295
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-406276
FILM NUMBER: 211090548
BUSINESS ADDRESS:
STREET 1: 1111 BROADWAY, SUITE 1300
CITY: OAKLAND
STATE: CA
ZIP: 94607
BUSINESS PHONE: (510) 227-2102
MAIL ADDRESS:
STREET 1: 1111 BROADWAY, SUITE 1300
CITY: OAKLAND
STATE: CA
ZIP: 94607
D
1
primary_doc.xml
X0708
D
LIVE
0001872295
Aditum Bio Fund 2, L.P.
1111 BROADWAY, SUITE 1300
OAKLAND
CA
CALIFORNIA
94607
(510) 227-2102
DELAWARE
None
None
Limited Partnership
true
2021
N/A
Aditum Bio GP 2, LLC
1111 Broadway, Suite 1300
Oakland
CA
CALIFORNIA
94607
Director
The General Partner of the Issuer (the "General Partner")
Joseph
Jimenez
1111 Broadway, Suite 1300
Oakland
CA
CALIFORNIA
94607
Director
Managing Director of the General Partner of the Issuer
Mark
Fishman
1111 Broadway, Suite 1300
Oakland
CA
CALIFORNIA
94607
Director
Co-Founder and Chairman of the Scientific Advisory Board
Praveena
Kandula
1111 Broadway, Suite 1300
Oakland
CA
CALIFORNIA
94607
Director
Managing Director of the General Partner of the Issuer
Ilan
Zipkin
1111 Broadway, Suite 1300
Oakland
CA
CALIFORNIA
94607
Director
Managing Director of the General Partner of the Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
false
true
false
true
false
0
250000000
0
250000000
false
0
0
0
0
The General Partner of the Issuer (or an affiliate thereof) is entitled to a management fee.
false
Aditum Bio Fund 2, L.P.
/s/Joseph Jimenez
Joseph Jimenez
Managing Director of the General Partner of the Issuer
2021-07-14